Back to Search
Start Over
Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C.
- Source :
-
Gastroenterology [Gastroenterology] 2011 Jul; Vol. 141 (1), pp. 128-40, 140.e1-2. Date of Electronic Publication: 2011 Mar 31. - Publication Year :
- 2011
-
Abstract
- Background & Aims: Patients with advanced chronic hepatitis C (CH-C) often are malnourished, but the effects of malnutrition on interferon (IFN) signaling and response to treatment have not been determined. We assessed the importance of the nutritional state of the liver on IFN signaling and treatment response.<br />Methods: We studied data from 168 patients with CH-C who were treated with the combination of pegylated-IFN and ribavirin. Plasma concentrations of amino acids were measured by mass spectrometry. Liver gene expression profiles were obtained from 91 patients. Huh-7 cells were used to evaluate the IFN signaling pathway, mammalian target of rapamycin complex 1 (mTORC1), and forkhead box O (FoxO). Antiviral signaling induced by branched-chain amino acids (BCAAs) was determined using the in vitro hepatitis C virus replication system.<br />Results: Multivariate logistic regression analysis showed that Fischer's ratio was associated significantly with nonresponders, independent of interleukin-28B polymorphisms or the histologic stage of the liver. Fischer's ratio was correlated inversely with the expression of BCAA transaminase 1, and was affected by hepatic mTORC1 signaling. IFN stimulation was impaired substantially in Huh-7 cells grown in medium that was low in amino acid concentration, through repressed mTORC1 signaling, and increased Socs3 expression, which was regulated by Foxo3a. BCAA could restore impaired IFN signaling and inhibit hepatitis C virus replication under conditions of malnutrition.<br />Conclusions: Malnutrition impaired IFN signaling by inhibiting mTORC1 and activating Socs3 signaling through Foxo3a. Increasing BCAAs to up-regulate IFN signaling might be used as a new therapeutic approach for patients with advanced CH-C.<br /> (Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Adult
Aged
Base Sequence
Cell Line, Tumor
Drug Therapy, Combination
Female
Forkhead Box Protein O3
Forkhead Transcription Factors genetics
Genotype
Hepacivirus drug effects
Hepacivirus genetics
Hepacivirus growth & development
Hepatitis C, Chronic complications
Hepatitis C, Chronic diagnosis
Hepatitis C, Chronic metabolism
Humans
Interferon alpha-2
Interferons
Interleukins genetics
Interleukins metabolism
Japan
Liver metabolism
Liver virology
Liver Cirrhosis metabolism
Liver Cirrhosis virology
Male
Malnutrition virology
Mechanistic Target of Rapamycin Complex 1
Middle Aged
Molecular Sequence Data
Multiprotein Complexes
Odds Ratio
Polymorphism, Genetic
Proteins genetics
Proteins metabolism
RNA Interference
RNA, Viral blood
Recombinant Proteins
Regression Analysis
Ribavirin therapeutic use
Severity of Illness Index
Suppressor of Cytokine Signaling 3 Protein
Suppressor of Cytokine Signaling Proteins genetics
Suppressor of Cytokine Signaling Proteins metabolism
TOR Serine-Threonine Kinases genetics
Transaminases metabolism
Transfection
Treatment Outcome
Viral Load
Virus Replication drug effects
Antiviral Agents therapeutic use
Forkhead Transcription Factors metabolism
Hepatitis C, Chronic drug therapy
Interferon-alpha therapeutic use
Liver drug effects
Malnutrition metabolism
Nutritional Status
Polyethylene Glycols therapeutic use
Signal Transduction drug effects
TOR Serine-Threonine Kinases metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1528-0012
- Volume :
- 141
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Gastroenterology
- Publication Type :
- Academic Journal
- Accession number :
- 21458454
- Full Text :
- https://doi.org/10.1053/j.gastro.2011.03.051